4 ms·
I believe he got just got either Ipilimumab and Nivolumab as a combo therapy or Pembrolizumab. He's a researcher who focuses on neo-adjuvant (use therapy befor
by crispycas12 2y ago
I believe he got just got either Ipilimumab and Nivolumab as a combo therapy or Pembrolizumab. He's a researcher who focuses on neo-adjuvant (use therapy before resection) therapy in melanomas. It was a good gamble to try the same paradigm in Glioblastomas
- mcbain 2y agohttps://www.nature.com/articles/s41591-025-03512-1 https://www.nature.com/articles/s41591-025-03512-1 Ipi/nivo/relatlimab and then a peptide vaccine that they haven't written up yet.
- femto 2y agoThanks for the link to the paper. I notice that the abstract has a link to the page for the upcoming trial: https://clinicaltrials.gov/study/NCT06816927 https://clinicaltrials.gov/study/NCT06816927 It will be interesting to follow its progress.
- femto 2y agoIn news announced a few minutes ago, Richard Scolyer's cancer has come back and the prognosis is a few months to live. https://www.smh.com.au/lifestyle/health-and-wellness/former-australian-of-the-year-down-to-months-not-years-after-brain-tumour-returns-20250309-p5li64.html https://www.smh.com.au/lifestyle/health-and-wellness/former-...